Invesco’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Buy |
60,555
+11,312
| +23% | +$85.2K | ﹤0.01% | 3195 |
|
|
2025
Q1 | $373K | Sell |
49,243
-10,310
| -17% | -$78K | ﹤0.01% | 3264 |
|
|
2024
Q4 | $725K | Buy |
59,553
+1,395
| +2% | +$17K | ﹤0.01% | 3041 |
|
|
2024
Q3 | $974K | Buy |
58,158
+8,797
| +18% | +$147K | ﹤0.01% | 2907 |
|
|
2024
Q2 | $861K | Buy |
49,361
+1,954
| +4% | +$34.1K | ﹤0.01% | 3001 |
|
|
2024
Q1 | $808K | Buy |
47,407
+36,784
| +346% | +$627K | ﹤0.01% | 3082 |
|
|
2023
Q4 | $108K | Buy |
+10,623
| New | +$108K | ﹤0.01% | 3666 |
|
|
2023
Q1 | – | Sell |
-10,057
| Closed | -$106K | – | 3864 |
|
|
2022
Q4 | $106K | Sell |
10,057
-76
| -0.8% | -$802 | ﹤0.01% | 3789 |
|
|
2022
Q3 | $129K | Buy |
10,133
+19
| +0.2% | +$242 | ﹤0.01% | 3763 |
|
|
2022
Q2 | $129K | Sell |
10,114
-1,720
| -15% | -$21.9K | ﹤0.01% | 3811 |
|
|
2022
Q1 | $124K | Buy |
11,834
+203
| +2% | +$2.13K | ﹤0.01% | 3811 |
|
|
2021
Q4 | $180K | Buy |
11,631
+2,504
| +27% | +$38.8K | ﹤0.01% | 3770 |
|
|
2021
Q3 | $205K | Buy |
+9,127
| New | +$205K | ﹤0.01% | 3759 |
|